• Explore /
  • Poster
  • / Genomic risk prediction of aromatase inhibitor-related arthralgias (AIA) in breast cancer (BC) patients using a novel analytical algorithm (NAA).

Genomic risk prediction of aromatase inhibitor-related arthralgias (AIA) in breast cancer (BC) patients using a novel analytical algorithm (NAA).

Abstract Poster

Authors

Raquel Reinbolt

Raquel E. Reinbolt

The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Columbus, OH

Raquel E. Reinbolt , Stephen T. Sonis , Cynthia Dawn Timmers , Juan Luis Fernández-Martínez , Enrique J. deAndrés-Galiana , Sepehr Hashemi , Karin Miller , Bhuvaneswari Ramaswamy , Robert Wesolowski , Anne M. Noonan , Shabana Jaynul Dewani , Nicole Olivia Williams , Sagar D. Sardesai , Robert Pilarski , Maryam B. Lustberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Palliative Care and Symptom Management

Citation

J Clin Oncol 35, 2017 (suppl; abstr 10102)

DOI

10.1200/JCO.2017.35.15_suppl.10102

Abstract #

10102

Poster Bd #

91

Abstract Disclosures

Similar Posters

First Author: Catalin Barbacioru

First Author: Dmitry Yu. Gvaldin

Poster

2020 ASCO Virtual Scientific Program

Identification of pathogenic <em>ROS1</em> alterations in cell-free DNA (cfDNA) from patients with breast cancer.

Identification of pathogenic ROS1 alterations in cell-free DNA (cfDNA) from patients with breast cancer.

First Author: Jeremy Meyer Force

First Author: Zaid Abdel Rahman